The Leu144Gln mutation of human cardiac Troponin I

(other names:  L144Q)

SEQUENCE
exon 7
nucleotide change T>A
nucleotide pos. in gene 4691
UCSC Golden Path position 60357328
amino acid changeLeu>Gln
charge change 0
codon change CTG>CAG
transcript change missense
translation change substitution


mutated amplimer sequence:
gcctaagccgggaagagactggtaaggcctcggtactggaagacgagata
aggagaataaaaaaggagtgtaggatggaggagttgggtgtgcgggaaat
ggaaggagaagtacccaccccctcgtgtgcccccagattgcagatctgac
tcagaagatctttgaccttcgaggcaagtttaagcggcccacccAgcgga
gagtgaggatctctgcagatgccatgatgcaggcgctgctgggggcccgg
gctaaggagtccctggacctgcgggcccacctcaagcaggtgaagaagga
ggacaccgagaaggtgagtgtgggctaaggccaggaaagaggatgctgag
gggaagggctgtgggtgccaacaaccctaggcctgagggcagatggtgct
tggagttggaggtagaagcagctagtaaggggtcctc


RESTRICTION ENZYME
no information

 
disease Restrictive CM

 
    References and comments
  1. Mogensen J, Kubo T, Duque M, Uribe W, Shaw A, Murphy R, Gimeno JR, Elliott P, McKenna WJ.
    Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.
    J Clin Invest 2003 Jan;111(2):209-16. (PubMed:12531876)
  2. Gomes AV, Liang J, Potter JD.
    Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development.
    J Biol Chem. 2005 Sep 2;280(35):30909-15. Epub 2005 Jun 15. (PubMed:15961398)
 

Last modified: April 24, 2006